Biohit Signs Licensing Agreement With GrandPharma

Published: Jan 09, 2013

Licensing agreement has been signed between Finnish healthcare company Biohit Oyj and Chinese pharmaceutical company GrandPharma. The agreement gives GrandPharma the rights to use intellectual property rights and know-how of Biohit to exclusively manufacture market and distribute in China the acetaldehyde binding products developed by Biohit. GrandPharma is a large scale, modern and comprehensive distributor and producer of pharmaceutical in pharmaceutical enterprise.

Back to news